astragaloside a has been researched along with Proteinuria in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abulikemu, Z; Aierken, R; Dilixiati, N; Huang, Y; Li, XY; Sui, S; Tuerxun, D; Zhang, YM | 1 |
Chen, D; Cheng, L; Pan, JH; Wang, ZS; Xie, XH; Xiong, F | 1 |
Chen, Y; Deng, Y; Fan, J; Wang, L; Zhang, M; Zheng, R; Zhong, Y; Zhu, R | 1 |
3 other study(ies) available for astragaloside a and Proteinuria
Article | Year |
---|---|
Astragaloside IV alleviates lipopolysaccharide-induced preeclampsia-like phenotypes via suppressing the inflammatory responses.
Topics: Animals; Blood Pressure; Cytokines; Disease Models, Animal; Female; Heart Rate; Inflammation; Lipopolysaccharides; NF-kappa B; Phenotype; Placenta; Placenta Growth Factor; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Proteinuria; Rats, Sprague-Dawley; RNA, Messenger; Saponins; Toll-Like Receptor 4; Triterpenes; Urine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2021 |
Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
Topics: Analysis of Variance; Animals; Apoptosis; Blotting, Western; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Male; Podocytes; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reference Values; Saponins; Streptozocin; Triterpenes; Urinalysis | 2015 |
Astragaloside IV attenuates complement membranous attack complex induced podocyte injury through the MAPK pathway.
Topics: Actin Cytoskeleton; Animals; Astragalus propinquus; Cell Line; Complement Membrane Attack Complex; Cytoprotection; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glomerulonephritis, Membranous; Immunohistochemistry; Kidney Glomerulus; L-Lactate Dehydrogenase; MAP Kinase Signaling System; Mice; Phosphorylation; Podocytes; Protective Agents; Proteinuria; Saponins; Time Factors; Triterpenes | 2012 |